Hyundai and Kia set to report a rebound in operating profit for the second quarter on strong demand in global markets, say analysts
In the year-ago quarter, Hyundai's and Kia's operating profits more than halved to 590 billion won and 145 billion won, respectively, as the coronavirus outbreak drove down global vehicle demand.
Hyundai and Kia are forecast to report sales of 29.06 trillion won and 17.75 trillion won, respectively, in the second quarter, up from 21.86 trillion won and 11.37 trillion won a year earlier, reports Yonhap news agency.
Behind the carmakers' quarterly earnings rebound are robust sales of their high-end vehicles in the domestic and the world's most important U.S. markets among others, analysts said.
"A combination of (their) improved product mix, lower incentives and higher average selling prices (particularly) in the U.S. market helped offset the impact of chip shortages and boost profits in the second quarter,"
From January to June, Hyundai and Kia sold a combined 3.47 million vehicles, up 25 percent from 2.77 million units in the same period of last year.
They aim to sell a total of 7.08 million autos this year, 1.7 percent lower than the 7.2 million units they sold last year.
In the second half, Hyundai and Kia said they will continue to focus on promoting their new models, including Hyundai's all-electric IONIQ 5 crossover utility vehicle and Kia's K8 sedan and all-electric EV6 model, to ride out the COVID-19 pandemic crisis.
SEE ALSO -
Google Calendar’s new RSVP option will let you specify how you want to attend a meeting
TCS has loaded up half a million peeps as it expects many to move on
Popular on BI
- RIL to start churning free cash flows as operating income rises, says JP Morgan
- Indian equity market enters coveted USD 4-trillion market cap club for first time
- Lesser known facts about Charlie Munger, Warren Buffet’s second and accomplice
- Fedbank Financial Services IPO allotment – How to check allotment, GMP, listing date and more
- Flair Writing IPO allotment – How to check allotment, GMP, listing date and more